2024 | | Clinical application of whole-genome sequencing of solid tumors for precision oncology | 강석윤, 고영화, 곽규성, 권민석, 김석휘, 김선일, 김세혁, 김장희, 김재근, 김창우, 김철호, 김태환, 노성현, 노진, 노충균, 박지원, 박지은, 백수연, 손상용, 신승수, 안미선, 양민재, 유우식, 윤재성, 이기명, 이길호, 이다근, 이현우, 임선교, 장전엽, 정윤정, 조대성, 최용원, 최진혁, 하태양, 한상욱, 허지미, 허훈 |
2024 | | Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study | 강석윤, 고영화, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
2024 | | Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset | 최진혁 |
2023 | | Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study | 강석윤, 권민석, 김태환, 손상용, 신승수, 안미선, 이현우, 최용원, 최진혁, 한상욱, 허훈 |
2023 | | Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial | 최진혁 |
2023 | | Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01) | 최진혁 |
2022 | | Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01) | 최진혁 |
2022 | | The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study | 강석윤, 김세혁, 노오규, 노태훈, 신승수, 안미선, 오영택, 이현우, 최용원, 최진혁 |
2022 | | Erratum: Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin | 강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성 |
2022 | | Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin | 강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성 |
2022 | | Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01) | 최진혁 |
2022 | | Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort study | 강석윤, 김태환, 안미선, 이현우, 최용원, 최진혁 |
2022 | | Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data | 강석윤, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
2021 | | Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data | 강석윤, 김태환, 신승수, 안미선, 이현우, 조헌도, 최용원, 최진혁 |
2021 | | PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | 최진혁 |
2021 | | Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia | 강석윤, 김태환, 박준성, 안미선, 이현우, 정성현, 최용원, 최윤석, 최진혁 |
2021 | | Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer | 강석윤, 김장희, 김태규, 노진, 안미선, 임현이, 정용식, 최진혁 |
2021 | | A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer | 최진혁 |
2020 | | Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01) | 최진혁 |
2020 | | Combination versus single-agent as palliative chemotherapy for gastric cancer | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2019 | | Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy? | 강석윤, 안미선, 이현우, 최용원, 최진혁 |
2019 | | Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naive Korean Patients with Extensive-Disease Small Cell Lung Cancer | 최진혁 |
2019 | | The role of surgical resection before palliative chemotherapy in advanced gastric cancer | 강석윤, 박준성, 손상용, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한상욱, 허훈 |
2018 | | Should combination chemotherapy be used in all advanced gastric cancer patients? | 강석윤, 안미선, 이현우, 최용원, 최진혁 |
2018 | | Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy | 강석윤, 안미선, 이현우, 최용원, 최진혁 |
2018 | | P2.12-01: Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study | 최진혁 |
2018 | | 469: Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis | 강석윤, 박준성, 박태준, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients | 강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호 |
2018 | | Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma | 강석윤, 김장희, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호 |
2018 | | The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2017 | | Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer? | 최용원, 최진혁 |
2017 | | Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes | 강석윤, 임현이, 전미선, 정용식, 최진혁, 한세환 |
2016 | | The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer | 박광주, 안영실, 오영택, 윤준기, 이수진, 최진혁 |
2016 | | Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer | 노오규, 박래웅, 박성용, 안미선, 오영택, 윤덕용, 이현우, 전미선, 최진혁, 허재성 |
2016 | | High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy | 강석윤, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호 |
2016 | | Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic Treatments | 강석윤, 김상원, 전미선, 정용식, 최진혁, 한세환 |
2016 | | Baseline neutrophil-lymphocyte ratio is associated with baseline and subsequent presence of brain metastases in advanced non-small-cell lung cancer | 고영화, 안미선, 이현우, 최용원, 최진혁 |
2016 | | A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806) | 강석윤, 최진혁 |
2015 | | Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation. | 강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2015 | | Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer? | 강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁 |
2015 | | Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04. | 최진혁 |
2015 | | Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome? | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 조용관, 최용원, 최진혁, 한상욱, 한재호 |
2014 | | Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial | 최진혁 |
2014 | | Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP. | 강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁 |
2014 | | Clinical significance of cryptic chromosomal translocations detected by multiplex RT-PCR in patients with acute leukemia. | 강석윤, 박준성, 안미선, 이현우, 정성현, 조성란, 최진혁 |
2013 | | Four Cases of Metastasectomy for Pulmonary Metastasis of Nasopharyngeal Carcinoma | 선주성, 안미선, 최진혁, 최호, 한재호 |
2013 | | 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection. | 강석윤, 박준성, 안미선, 이광재, 이순영, 이현우, 정성현, 조용관, 최진혁, 한상욱 |
2012 | | Acquired hemophilia successfully treated with activated prothrombin complex concentrate and immunosuppressant combination: a case report | 강석윤, 박준성, 안미선, 이현우, 정성현, 최진혁 |
2012 | | Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection | 강석윤, 김영배, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 조용관, 최진혁, 한상욱, 한재호 |
2011 | | Change in Cancer Pain Management in Korea Between 2001 and 2006: Results of Two Nationwide Surveys. | 최진혁 |